Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 1.78% to $502.45 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index SPX rising 0.74% to ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell ...

Therefore Moneycontrol doesn't bear any responsibility for any trading losses you might incur as a result of using this data.

Vertex (NASDAQ:VERX – Free Report) had its price target upped by The Goldman Sachs Group from $42.00 to $59.00 in a report released on Thursday,Benzinga reports.The brokerage currently has a buy ...

Vertex (VERX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Vertex (VERX – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Chris Quintero from ...

Morgan Stanley analyst Chris Quintero raised the firm’s price target on Vertex (VERX) to $62 from $50 and keeps an Overweight rating on the shares. The firm has greater conviction in Vertex being a ...

Vertex (NASDAQ:VERX – Free Report) had its price target lifted by JMP Securities from $47.00 to $61.00 in a report published on Thursday,Benzinga reports. JMP Securities currently has a market ...

Vertex has reached a key moment because the U.S. Food and Drug Administration (FDA) is reviewing its candidate, suzetrigine, ...